May 31, 2022 9:13am EDT FibroBiologics Presents Preclinical Data at the 2022 Consortium of Multiple Sclerosis Centers Annual Meeting
Mar 10, 2022 9:38am EST FibroBiologics Adds Microbiologist Kathleen "Kate" Rubins, Ph.D. to Scientific Advisory Board
Nov 16, 2021 10:07am EST FibroBiologics Secures $100 Million Capital Commitment from GEM as Company Seeks to Go Public